BIOMARIN PHARMACEUTICAL INC 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001048477-26-000004
- Form type
- 10-K
- CIK
- 0001048477
- Primary document
- https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOMARIN PHARMACEUTICAL INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $3.2B | - | - |
| Cost Of Revenue | $717.4M | - | - |
| Operating Income | $409.5M | - | - |
| Net Income | $348.9M | - | - |
| Eps Basic | 1.82 | - | - |
| Eps Diluted | 1.8 | - | - |
| Cash And Equivalents | $1.3B | - | - |
| Total Assets | $7.6B | - | - |
| Total Liabilities | $1.5B | - | - |
| Shareholders Equity | $6.1B | - | - |
| Operating Cash Flow | $828.0M | - | - |
| Capital Expenditures | $103.0M | - | - |